A Pilot Study of a Strategy and Computer-based Intervention to Enhance Daily Cognitive Functioning After Stroke
Study Details
Study Description
Brief Summary
This is an initial pilot study to test feasibility, participant engagement and satisfaction, and clinical and neurobiological target engagement of a behavioral treatment called "ASCEND" that combines computer-based cognitive training and coaching of cognitive strategies to improve daily cognitive functioning in individuals with stroke.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: ASCEND ASCEND combines computer-based cognitive training exercises, homework exercises to enhance cognition, and coaching sessions delivered in-person and via telephone/videoconference by a neuropsychologist. ASCEND includes 24 total computer training sessions of 30 minutes each, for a total of 12 hours. ASCEND includes 8 coaching sessions of 45 minutes each. The computer exercises aim to improve attention, working memory (WM), and cognitive control through a series of engaging and interactive computer games (e.g., card games, driving simulation). The homework exercises and coaching sessions aim to assist the participant in generalizing and transferring skills from the computer exercises to daily life and to develop further strategies to compensate for attention and WM difficulties in daily life. |
Behavioral: ASCEND
ASCEND is a behavioral intervention that combines computer-based cognitive exercise, strategy coaching with a neuropsychologist, and homework exercises in order to improve attention, working memory, and cognitive control after stroke.
|
Outcome Measures
Primary Outcome Measures
- Participant satisfaction with ASCEND, as measured by the Client Satisfaction Questionnaire-8 (CSQ-8) [5 weeks (at the conclusion of treatment)]
The CSQ-8 is a self-report measure of participant satisfaction with the intervention. Scores range from 8-32 with higher scores indicating greater satisfaction.
- Participant impression of ASCEND as a credible treatment to improve cognition, as measured by the Credibility and Expectancy Questionnaire (CEQ). [5 weeks (at the conclusion of treatment)]
The CEQ is a self-report measure that assesses participants' perceived benefit and improvement from the intervention. Each item is scored on a 1-9 Likert-type scale or as a percentage rating from 0% to 100% in 10% increments.
Secondary Outcome Measures
- Change in auditory attention and working memory, as measured by the Digit Span test [Baseline, 5 weeks]
Performance-based measure of attention/working memory with scores ranging from 0-48, with higher scores indicating better performance.
- Change in visual attention and working memory, as measured by the Symbol Span test [Baseline, 5 weeks]
Performance-based measure of attention/working memory with scores ranging from 0-50, with higher scores indicating better performance.
- Change in divided attention and working memory, as measured by the Symbol-Digit Modalities Test [Baseline, 5 weeks]
Performance-based measure of divided attention/working memory with scores ranging from 0-120, with higher scores indicating better performance.
- Change in divided attention and processing speed, as measured by the Trail Making Test [Baseline, 5 weeks]
Performance-based and timed measure of divided attention/processing speed with lower scores indicating better performance (faster completion time).
- Change in selective attention and inhibitory control, as measured by the Stroop Test [Baseline, 5 weeks]
Performance-based and timed measure of selective attention and inhibition, with higher scores indicating better performance.
- Change in rapid working memory and mental arithmetic, as measured by the Paced Auditory Serial Addition Test (PASAT) [Baseline, 5 weeks]
Performance-based and timed measure of rapid working memory, with higher scores indicating better performance.
- Change in attention and working memory as measured by the Mental Control test [Baseline, 5 weeks]
Performance-based measure of simple auditory attention and working memory. Scores range from 0-12 with higher scores indicating better performance.
- Change in executive functioning as measured by the Weekly Calendar Planning Activity [Baseline, 5 weeks]
Performance-based measure of executive functioning. Higher scores indicate better performance.
- Change in self-reported executive functioning as measured by the Behavior Rating Inventory of Executive Function-Adult [Baseline, 5 weeks]
Self-report measure of executive functioning. Higher scores indicate greater problems with executive dysfunction in daily life.
- Change in self-reported cognitive symptoms due to stroke, as measured by the Patient Reported Evaluation of Cognitive State (PRECIS). [Baseline, 5 weeks]
Self-report measure of cognitive difficulties after stroke. Scores range from 0-128 with higher scores indicating greater cognitive problems in daily life due to stroke.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
History of first-time stroke, minimum of 6 months prior to enrollment
-
English speaking
-
Ability to comprehend sufficiently to participate in the treatment.
-
Subjective or objective evidence of mild cognitive impairment
-
Willingness to participate in full study duration
-
Has computer that meets specification for the training program software.
-
Physically able to operate a computer keyboard and mouse.
-
Not concurrently receiving other cognitive rehabilitation services
-
Cognitively able to perform basic self-care activities (e.g., dressing, grooming, eating).
Exclusion Criteria:
-
History of neurologic disease other than stroke
-
History of severe mental illness or substance use disorder, or current major depressive episode.
-
History of dementia or dependence in basic self-care activities due to cognitive deficits
-
Contraindications to MRI
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | NewYork-Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | United States | 10065 |
Sponsors and Collaborators
- Weill Medical College of Cornell University
Investigators
- Principal Investigator: Abhishek Jaywant, PhD, Weill Medical College of Cornell University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 19-06020310